- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Study reveals drug volume, prices on the rise
Total retail prescription drug sales for 1999 are expected to exceed $121.6 billion.
Total retail prescription drug sales for 1999 are expected to exceed $121.6 billion, according to a study released by the National Association of Chain Drug Stores. The estimate is an 18% increase over the 1998 year-end level of $103.5 billion. NACDS also projects an 8% increase in the number of prescriptions dispensed in retail pharmacies.
According to the study, 2.97 billion prescriptions will have been dispensed by year's end.
Several factors are responsible for the increases, according to Phil Schneider, the managing director of public affairs for the NACDS. "Demographics, product introduction, recognition of the role of medicines in treating illnesses earlier and quicker and advertising can make patients more informed or cause them to seek more health care," explained Schneider.
Schneider cautioned that the figures must be looked at in relation to health care costs as a whole.
"Frequently people say 'rise in the cost of prescription drugs' and they mean rise in prescription drug expenditures," Schneider said. "There are two components in the rise of prescription drug expenditures: the increase in the number of prescriptions and the price of those prescriptions. So while overall prescription expenditures may be increasing in the 10% to 12% rate, total health care expenditures are not increasing at that level." PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Seeking Sustainable Solutions: Can Passion and Profit Coexist in Pharma ESG Efforts?
October 15th 2024Industry leaders gather to discuss different ways life sciences organizations can champion their environmentally-conscious younger employees while combatting still-entrenched public mistrust.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
